Abiomed (GB:0H7S)

Abiomed (0H7S) Financial Statements


Abiomed Financial Overview

Abiomed's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Abiomed is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Jun 22Mar 22Dec 21Sep 21
Income Statement-
Total Revenue$ 265.92M$ 277.15M$ 269.85M$ 261.18M$ 248.14M
Gross Profit$ 217.04M$ 224.52M$ 218.39M$ 213.55M$ 204.26M
EBIT$ 57.99M$ 66.05M$ 65.00M$ 65.06M$ 60.44M
EBITDA$ 64.72M$ 72.67M$ 72.29M$ 71.99M$ 67.40M
Net Income Common Stockholders$ 106.13M$ 54.55M$ 60.33M$ 45.75M$ 56.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 820.37M$ 844.32M$ 758.61M$ 669.22M$ 650.56M
Total Assets$ 1.70B$ 1.70B$ 1.67B$ 1.59B$ 1.53B
Total Debt$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ -820.37M$ -844.32M$ -758.61M$ -669.22M$ -650.56M
Total Liabilities$ 156.76M$ 167.44M$ 170.07M$ 159.94M$ 145.47M
Stockholders Equity$ 1.54B$ 1.54B$ 1.50B$ 1.43B$ 1.38B
Cash Flow-
Free Cash Flow$ 7.81M$ 61.32M$ 64.08M$ 84.01M$ 53.35M
Operating Cash Flow$ 13.42M$ 68.10M$ 78.97M$ 90.49M$ 60.57M
Investing Cash Flow$ 101.57M$ 8.11M$ -92.57M$ -180.02M$ 660.00K
Financing Cash Flow$ -110.18M$ -23.94M$ 4.75M$ -6.16M$ 6.68M
Currency in USD

Abiomed Earnings and Revenue History

Abiomed Debt to Assets

Abiomed Cash Flow

Abiomed Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis